Updated Clinical Classification of Pulmonary Hypertension - Simonneau, Gérald; Robbins, Ivan M.; Beghetti, Maurice; Channick, Richard N.; Delcroix, Marion; Denton, Christopher P.; Elliott, C. Gregory; Gaine, Sean P.; Gladwin, Mark T.; Jing, Zhi-Cheng; Krowka, Michael J.; Langleben, David; et al. (Journal of the American College of Cardiology, 2009)
Keywords: Algorithms; Anticoagulants - therapeutic use; Antihypertensive Agents - administration & dosage; Calcium Channel Blockers - therapeutic use; Cardiology; Cardiovascular; Cardiovascular disease; Classification; clinical classification; Clinical trials; Comorbidity; Defects; Drug therapy; Endothelin Receptor Antagonists; Epoprostenol - administration & dosage; Evidence-Based Medicine; Family medical history; Genetic counseling; Humans; Hypertension, Pulmonary - classification; Hypertension, Pulmonary - drug therapy; Hypertension, Pulmonary - epidemiology; Internal Medicine; Mutation; Prognosis; pulmonary arterial hypertension; Pulmonary hypertension; Randomized Controlled Trials as Topic; Scleroderma, Systemic - epidemiology; Surgery; Treatment Outcome; United States--US; California; ESRD; BMPR2; OR; pulmonary hypertension; PPH; IPAH; PVR; POPH; HIV; PCH; SCD; PAH; PH; clinical classification; TRV; CTEPH; pulmonary arterial hypertension; CHD; PAP; PVOD; odds ratio; pulmonary arterial pressure; primary pulmonary hypertension; sickle cell disease; congenital heart disease; bone morphogenetic protein receptor type 2; tricuspid regurgitation jet velocity; end-stage renal disease; idiopathic pulmonary arterial hypertension; chronic thromboembolic pulmonary hypertension; human immunodeficiency virus; pulmonary veno-occlusive disease; pulmonary vascular resistance; pulmonary capillary hemangiomatosis; portopulmonary hypertension